Francesca Barone
Chief Tech/Sci/R&D Officer bei CANDEL THERAPEUTICS, INC.
Vermögen: 44 918 $ am 31.03.2024
Aktive Positionen von Francesca Barone
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CANDEL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.11.2020 | - |
Karriereverlauf von Francesca Barone
Ehemalige bekannte Positionen von Francesca Barone
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.05.2019 | 01.11.2020 |
University of Birmingham | Corporate Officer/Principal | 01.01.2010 | 01.05.2019 |
Institute of Translational Medicine | Corporate Officer/Principal | - | - |
Ausbildung von Francesca Barone
Sapienza University of Rome | Doctorate Degree |
King's College London | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 4 |
Vereinigte Staaten | 3 |
Italien | 2 |
Operativ
Corporate Officer/Principal | 3 |
Doctorate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CANDEL THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Institute of Translational Medicine |
- Börse
- Insiders
- Francesca Barone
- Erfahrung